Document is current
Any future updates will be listed below
-
Authors
Anan, Yuhei
Mashiko, Takafumi
Matsuzono, Kosuke
Miura, Kumiko
Ozawa, Tadashi
Suzuki, Masayuki
Ozawa, Misato
Kameda, Tomoaki
Koide, Reiji
Tanaka, Ryota
Fujimoto, Shigeru https://orcid.org/0000-0002-6295-4737
- License Information
-
More Information
Article History
Received: 12 June 2021
Accepted: 1 November 2021
First Online: 8 November 2021
Declarations
:
: Not applicable.
: The present study was approved by the local institutional ethics committee (Rin-Dai 19–099).
: All patients provided informed consent to participate in the present study prior to enrolment.
: All patients provided informed consent to participate in the present study prior to enrolment.
: S.F. received personal lecture fees: not related to the current work: Nippon Boehringer Ingelheim, Co., Ltd.; Bayer Yakuhin, Ltd.; Pfizer Japan Inc.; DAIICHI SANKYO Co., Ltd.; Eisai Co., Ltd.; Bristol-Myers Squibb Co.; R.T. received personal lecture fee: not related to the current work: Takeda Pharmaceutical Co., Ltd.; Nippon Boehringer Ingelheim, Co., Ltd.; Dai-Nippon Sumitomo Pharma Co., Ltd.; Bayer Yakuhin, Ltd.; Otsuka Pharmaceutical, Co., Ltd.; Pfizer Japan Inc.; DAIICHI SANKYO Co., Ltd.; Eisai Co., Ltd.; Bristol-Myers Squibb Co.; Stryker Japan.
